HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Willem Flameng Bart Meuris Paul Herijgers Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Flameng, W. Articles by Herregods, M.-C. Search for Related Content PubMed PubMed Citation Articles by Flameng, W. Articles by Herregods, M.-C. Related Collections Valve disease

Ann Thorac Surg 2006;82:530-536
© 2006 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Prosthesis–Patient Mismatch is Not Clinically Relevant in Aortic Valve Replacement Using the Carpentier-Edwards Perimount Valve

^a Department of Cardiac Surgery, University Clinic Gasthuisberg, Leuven, Belgium
^b Department of Cardiology, University Clinic Gasthuisberg, Leuven, Belgium

Accepted for publication March 28, 2006.

^_* Address correspondence to Prof Dr Flameng, Cardiac Surgery, University Clinic Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium (Email: willem.flameng{at}med.kuleuven.be).

BACKGROUND: Previous studies have shown that prosthesis–patient mismatch (PPM) results in higher early and late mortality after bioprosthetic aortic valve replacement. Careful selection of stented bioprostheses was recommended to avoid inadequate effective orifice area. We studied the incidence of PPM and its potential effects on clinical outcome in patients undergoing aortic valve replacement using the Carpentier-Edwards Perimount bioprosthesis.

METHODS: Independent predictors of early and late mortality and hospital readmission for cardiac reasons were defined in 506 patients (mean age, 73 years; range, 57 to 87 years) by multivariate analysis. Mean follow-up was 6.1 ± 4.8 years; maximum follow-up was 18.6 years.

RESULTS: The incidence of severe PPM (effective orifice area index < 0.65 cm²/m²) was 0.2% and of moderate PPM (effective orifice area index > 0.65 and < 0.85) was 20%. Multivariate analysis revealed that moderate PPM was not an independent predictor of early mortality, late mortality, or hospital readmission for cardiac reasons. Reduction of septal hypertrophy was similar in patients with and without moderate PPM.

CONCLUSIONS: The incidence of severe PPM is virtually nonexistent after aortic valve replacement using the Carpentier-Edwards Perimount valve. Moderate PPM is found in 20% of cases and is clinically irrelevant in this population.

This article has been cited by other articles:

				S Bleiziffer, W B Eichinger, I Hettich, D Ruzicka, M Wottke, R Bauernschmitt, and R Lange Impact of patient-prosthesis mismatch on exercise capacity in patients after bioprosthetic aortic valve replacement Heart, May 1, 2008; 94(5): 637 - 641. [Abstract] [Full Text] [PDF]

				J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al. Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626. [Abstract] [Full Text] [PDF]

				P. Totaro and V. Argano Patient prosthesis mismatch after mitral valve replacement: Myth or reality? J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 697 - 701. [Abstract] [Full Text] [PDF]

				R. Garcia Fuster, V. Estevez, I. Rodriguez, S. Canovas, O. Gil, F. Hornero, and J. Martinez-Leon Prosthesis patient mismatch with latest generation supra-annular prostheses. The beginning of the end? Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 462 - 469. [Abstract] [Full Text] [PDF]

				M. J. Dalmau, J. Maria Gonzalez-Santos, J. Lopez-Rodriguez, M. Bueno, A. Arribas, and F. Nieto One year hemodynamic performance of the Perimount Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the aortic position: a prospective randomized study Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 345 - 349. [Abstract] [Full Text] [PDF]

				S. Bleiziffer, W. B Eichinger, I. Hettich, R. Guenzinger, D. Ruzicka, R. Bauernschmitt, and R. Lange Prediction of valve prosthesis-patient mismatch prior to aortic valve replacement: which is the best method? Heart, May 1, 2007; 93(5): 615 - 620. [Abstract] [Full Text] [PDF]

				G. Gerosa, V. Tarzia, G. Rizzoli, and T. Bottio Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 847 - 849. [Full Text] [PDF]